Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04043897
PHASE2
Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis
Sponsor: Eugene F Yen, MD
View on ClinicalTrials.gov
Summary
This is an open label study looking at rifaximin therapy for the treatment of microscopic (collagenous or lymphocytic) colitis.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2018-06-29
Completion Date
2021-12
Last Updated
2021-04-15
Healthy Volunteers
No
Conditions
Interventions
DRUG
Rifaximin 550mg
Rifaximin 550mg
Locations (1)
NorthShore University HealthSystem
Evanston, Illinois, United States